Skip to main content
Equibles

Invesco Ltd.

Position in LYEL — Lyell Immunopharma, Inc.

CIK 914208 Atlanta, GA
Back to LYEL Full portfolio

Position in LYEL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$195,490
-$2,840,926 QoQ
Shares Held
13,914
-85.9% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 87 holders
Holding Since
Dec 2021
17 quarters on record
Voting authority Sole 0% Shared 98% None 2%

Common Shares in LYEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. LYEL ranks #245 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 8,043,052 $3,995,225,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,940,665 $2,457,162,245
3 ALNY
Alnylam Pharmaceuticals, Inc.
 3,754,318 $1,130,162,341
4 INCY
Incyte Corp
 4,080,461 $462,561,050
5 ARGX
Argenx SE
 443,990 $411,920,598
6 AXSM
Axsome Therapeutics, Inc.
 1,671,684 $409,178,086
7 MRNA
Moderna, Inc.
 5,780,299 $404,794,337
8 LGND
Ligand Pharmaceuticals Inc
 1,201,644 $379,827,645

All Filings in LYEL

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $195,490 13,914
2025-12-31 $3,036,416 98,649
2025-06-30 $113,231 12,809
2025-03-31 $203,836 378,880
2024-12-31 $260,609 407,205
2024-09-30 $560,208 405,949
2024-06-30 $589,953 406,865
2024-03-31 $912,973 409,406
2023-12-31 $603,550 311,109
2023-09-30 $430,285 292,712
2023-06-30 $924,300 290,661
2023-03-31 $682,478 289,186
2022-12-31 $193,181 55,672
2022-09-30 $2,279,600 310,996
2022-06-30 $365,901 56,120
2022-03-31 $296,354 58,684
2021-12-31 $89,311 11,539